Conservative Equities: Tomorrow’s winner?

Conservative Equities: Tomorrow’s winner?

09-12-2021 | Product webinar

Join the webinar with Pim van Vliet and Jan Sytze Mosselaar on Conservative Equities.

  • Pim  van Vliet, PhD
    van Vliet, PhD
    Head of Conservative Equities and Head of Quantitative Equities
  • Jan Sytze  Mosselaar
    Jan Sytze
    Portfolio Manager

Global equity investors have enjoyed annualized double-digit returns for years, helped by a phenomenal tech rally. However, the preference for growth stocks during Covid-19 has led low-volatility strategies to lag the wider market. Now, current demanding market valuations and the lack of attractive alternatives given ultra-low bond yields is making many investors wonder: what’s next?

In our latest webinar, Portfolio Managers Pim van Vliet and Jan Sytze Mosselaar will outline why they are more confident than ever that Conservative Equities will be attractive going forward. Their portfolios are trading at their highest margin of safety since the strategy began in 2006. Moreover, elevated market valuations usually mean higher downside risks in which low-risk stocks win through.

At the end of the session, we will have covered:

  • Why we buy less well-known companies that offer stability and attractive yields
  • The strong academic and empirical foundation that underpins Conservative Equities
  • How the strategy is robust if faced with corrections, inflation or slower earnings

The live webinar will take place on Thursday 9 December at 15:00 GMT/ 16:00 CET.


Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients. 

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). 

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile. 

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports. 

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

I Disagree